ASTRO

This page includes the latest news from the American Society of Radiation Oncology (ASTRO), including news and video coverage from the society's annual meeting. ASTRO is the premier radiation oncology society in the world, with more than 10,000 members who are physicians, nurses, biologist, physicists, radiation therapists, dosimetrists and other healthcare professionals who specialize in treating patients with radiation therapy. 

Varian Discloses First Preclinical Results of Flash Therapy in Cancer Treatment
News | Proton Therapy | April 09, 2019

April 9, 2019 — Varian, in partnership with the University of Maryland School of Medicine’s Department of Radiation...

ZON-PTC in Clinical Use With RayStation 8B and Hyperscan
News | Treatment Planning | March 19, 2019

March 19, 2019 — Zuid-Oost Nederland Protonen Therapie Centrum (ZON-PTC), Maastricht, Netherlands, recently treated...

What to Expect from the Proton Therapy Market in 2019-2020
News | Proton Therapy | March 13, 2019

March 13, 2019 — The number of new particle therapy rooms ordered worldwide dropped by almost 20 percent in 2018,...

Mississippi Cancer Center Combines RayStation and TomoTherapy for Prostate Cancer Case
News | Treatment Planning | March 08, 2019

March 8, 2019 — Anderson Regional Cancer Center in Meridian, Miss., has treated its first patient using the...

Philips Introduces IntelliSpace Portal 11 at ECR 2019
Technology | Advanced Visualization | February 27, 2019

February 27, 2019 — Philips announced the launch of IntelliSpace Portal 11, the latest release of the company’s...

FDA Clears Advancements for Viewray MRIdian Radiation Therapy System
Technology | Image Guided Radiation Therapy (IGRT) | February 21, 2019

February 21, 2019 — ViewRay Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to...

New Targeted Therapy for Recurrent Brain Tumors Implanted for First Time
News | Radiation Therapy | February 15, 2019

February 15, 2019 – University of Minnesota Health (M Health) is the first in the United States to begin offering...

Elekta Unity MR-Linac Earns FDA Clearance
Technology | Image Guided Radiation Therapy (IGRT) | February 07, 2019

February 7, 2019 — The Elekta Unity...

Stereotactic Radiotherapy Improves Long-Term Survival in Stage-IV Cancers
News | Stereotactic Body Radiation Therapy (SBRT) | January 31, 2019

January 31, 2019 — The first report from a phase II, multi-center clinical trial indicates...

Philips Collaborates With MIM Software on Radiation Therapy Treatment Planning
News | Treatment Planning | January 31, 2019

January 31, 2019 — Philips announced a collaboration with imaging solutions provider MIM Software Inc. to improve...

Laurent Levy, CEO of Nanobiotix, explains the use of his company’s nanoparticles to enhance the radiation sensitivity of tumor tissue to improve patient outcomes

Laurent Levy, CEO of Nanobiotix, explains the use of his company’s nanoparticles to enhance the radiation sensitivity of tumor tissue to improve patient outcomes. The metallic-based nanoparticles show up on CT scans so it can be used as a permanent fiduciary marker to track tumor response. The images show the initial tumor and enhancement areas due to the nanoparticles and the resulting outcomes following treatment. Photo by Dave Fornell

Feature | Radiation Oncology | January 30, 2019 | By Dave Fornell

Artificial intelligence (AI) has been the hot topic discussed at all trade shows, and the...

Sponsored Content | Videos | Radiation Therapy | January 18, 2019
Join Chris Toth, president of Varian’s Oncology Systems business, for a look at product introductions for 2018 plus a...
Brachytherapy Alone Superior Treatment for Intermediate-Risk Prostate Cancer
News | Brachytherapy Systems | January 04, 2019

January 4, 2018 — Patient-reported outcomes (PROs) indicated a significantly different clinician and patient-...

Sponsored Content | Videos | Radiation Oncology | November 30, 2018

Accuray's philosophy is to personalize treatments to exactly fit the patient. Senior Director of Marketing Andrew...

Immune Inflammatory Levels Linked to Disease-Free Survival in Prostate Cancer
News | Prostate Cancer | November 19, 2018

November 19, 2018 — Data from a validation study of a high-risk...

Videos | ASTRO | November 08, 2018

ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the...

Laurent Levy, CEO of Nanobiotix, explains the use of his company's nanoparticles to enhance the radiation sensitivity of tumor tissue to improve patient outcomes.

Laurent Levy, CEO of Nanobiotix, explains the use of his company's nanoparticles to enhance the radiation sensitivity of tumor tissue to improve patient outcomes. The images show the initial tumor and enhancement areas due to the nanoparticles and the resulting outcomes following treatment.

Blog | ASTRO | November 08, 2018 | Dave Fornell, Editor

Here are a few of the radiation oncology technology advancement takeaways seen at the 2018...

The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018

Fujifilm's first FDA-cleared ...